SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending strongly amid positive developments in its AI and Cloud divisions, fueled by news of H200 GPU availability in China. The community is actively discussing a significant technical breakout on high volume, with many anticipating a substantial re-rating for the Chinese tech giant as it gains recognition in the AI sector.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems (OSS) is generating significant excitement following a new pre-production order from a major U.S. defense contractor for AI-powered vision systems, coupled with a strategic asset sale to sharpen its core focus. The community is actively anticipating a much larger military contract and is bullish on OSS's undervalued position within the rapidly growing Edge AI and defense sectors, noting its notably low share float as a factor for potential rapid movement.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is a focal point of market discussion following its new "Meta Compute" initiative and recent nuclear energy partnerships aimed at powering its extensive AI infrastructure buildout. While these ambitious investments underline a long-term strategic shift towards AI, community sentiment is divided, with many debating the immediate impact on the stock amid reports of job cuts in the Reality Labs division. Investors are closely scrutinizing whether this significant capital allocation will translate into tangible returns and address the company's recent price stagnation compared to other tech giants.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as market participants navigate concerns over renewed tariff threats and a deepening debate around Federal Reserve independence. Despite these geopolitical and monetary policy uncertainties, the community notes a remarkably resilient market where dips are consistently bought, fueling discussions about a potential AI-driven 'zombie grind higher' and its long-term sustainability.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is trending after a recent CFO transition and mixed investor reactions to its preliminary Q4 results and a lowered price target, intensifying a significant decline in its stock value. The community is sharply divided, with bulls arguing the sell-off is an overreaction given strong user growth and AI integration into new learning areas, while bears express concern over its valuation, perceived AI threats, and alleged market manipulation.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is actively discussed as the market evaluates new 25% tariffs imposed on countries trading with Iran, fueling community debate on potential trade war implications, particularly with China. This geopolitical development unfolds as investors anticipate the upcoming CPI report, amid widespread discussion about market resilience despite ongoing concerns surrounding political influence on economic data and the Federal Reserve.

Solid Biosciences, Inc. is a life science company, which engages in the development of treatments for patients with Duchenne muscular dystrophy. It also focuses on developing treatments for neuromuscular and cardiac diseases. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Charlestown, MA.

Solid Biosciences Inc

Solid Biosciences is trending due to recent positive regulatory milestones, including an FDA Orphan Drug designation for its Friedreich's Ataxia program and Fast Track status for its CPVT gene therapy, alongside ongoing progress in its Duchenne Muscular Dystrophy clinical trials. The community is actively discussing the company's diversified gene therapy pipeline and differentiated capsid technology, with many investors anticipating upside given strong institutional backing and optimistic analyst sentiment. These developments position the company to potentially offer impactful treatments in the evolving gene therapy landscape for rare neuromuscular and cardiac conditions.

Lulu's Fashion Lounge Holdings, Inc. engages in providing an online website for clothing. It offers retailing of women's clothing, shoes, and accessories. The company was founded in 1996 and is headquartered in Chico, CA.

Lulus Fashion Lounge Holdings Inc

Lulus Fashion Lounge Holdings Inc. (LVLU) is trending strongly after activist investor Friedland Enterprises disclosed a 5% stake and called for significant governance reforms to unlock shareholder value. The community is actively discussing the investor's assertion that LVLU shares are "27x undervalued" compared to peers, fueling speculation of a potential low-float squeeze and sustained momentum.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is trending on the back of strong preliminary financial results, including significant year-over-year revenue growth and a record total contract value, alongside robust net revenue retention. The community is buzzing about the company's expanding partnerships in AI-powered precision oncology and its potential for substantial long-term growth, even as traders debate recent market volatility.

Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.

Biodesix Inc

Biodesix is trending following its preliminary Q4 and full-year 2025 results, which reported strong revenue growth exceeding guidance and reaffirmed Adjusted EBITDA positivity. The community is actively discussing the stock's significant price and volume surges, fueled by positive financial updates and speculation around its low float and high insider ownership. However, some market participants remain cautious about its long-term cash position and potential for dilution, while others are anticipating further upside in the oncology diagnostics company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bausch Health Cos Inc. (NYSE:BHC) Given Consensus Rating of "Hold" by Analysts

Shares of Bausch Health Cos Inc. (NYSE:BHC - Get Free Report) have been given an average recommendation of "Hold" by the six analysts that are currently covering the stock, Marketbeat reports. Six...

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference PR Newswire LAVAL, QC, Jan. 5, 2026...

Looking Into Bausch Health Companies Inc's Recent Short Interest

Q2 EPS Estimate for Bausch Health Cos Boosted by Analyst

Bausch Health Cos Inc. (NYSE:BHC - Free Report) - Equities researchers at Zacks Research increased their Q2 2026 earnings estimates for Bausch Health Cos in a research report issued on Tuesday...

What is Zacks Research's Estimate for TSE:BHC Q4 Earnings?

Bausch Health Companies Inc. (TSE:BHC - Free Report) - Stock analysts at Zacks Research reduced their Q4 2025 earnings per share (EPS) estimates for shares of Bausch Health Companies in a report...

Bausch Health Cos (NYSE:BHC) Trading Up 4.9% - Time to Buy?

Bausch Health Cos (NYSE:BHC) Trading 4.9% Higher - Should You Buy...

Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Hold" from Analysts

Bausch Health Cos Inc. (NYSE:BHC - Get Free Report) has received a consensus rating of "Hold" from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five...

Bausch Health Companies (TSE:BHC) Raised to "Hold" at Raymond James Financial

Raymond James Financial upgraded Bausch Health Companies to a "hold" rating in a report on Monday...

Bausch Health Cos (NYSE:BHC) Raised to Hold at Raymond James Financial

Raymond James Financial upgraded Bausch Health Cos to a "hold" rating in a report on Monday...

Nomura Holdings Inc. Sells 1,900,000 Shares of Bausch Health Cos Inc. $BHC

Nomura Holdings Inc. decreased its position in Bausch Health Cos Inc. (NYSE:BHC - Free Report) by 8.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$7.49
Prev Close	$7.41
Open	$7.43
Dividend Yield	0.00%
50-Day Moving Average	$6.82
Beta	1.17
Avg. Volume	2.67M
PE Ratio	7.64

52-Week High	$8.69
52-Week Low	$4.25
Market Capitalization	$2.75B
EPS (Annual)	-$0.125
Price to Book	-4.86
Revenue Per Employee	$464,975.84
Enterprise Value/EBITDA	N/A

BHC
Bausch Health Companies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BHC News

BHCBausch Health Companies Inc